4 things to know about molnupiravir - a new covid-19 drug
The availability, effectiveness, and safety of vaccines have dominated talks about stopping the COVID-19 pandemic over the past year, which have been at times heated. The Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for two medicines that patients can take at home in the days following the onset of COVID-19 symptoms to prevent severe disease and avoid coming to the hospital in December 2021. Centurion Healthcare is an excellent and noted Molnupiravir Capsules 200mg supplier in India . An early study revealed that Merck medicine reduced the risk of hospitalisation and mortality in patients with the mild-to-moderate disease by 50%, but a final analysis of the trial published in November, before the FDA approval, showed that the benefit had been reduced to 30%. Meanwhile, Pfizer announced that the medication it studied had an 89 per cent efficacy rate in averting hospitalisation and death in high-risk individuals. 1. How does Molnupiravir work?